Evidence map›Paper›PMID 39129890›Full record

ReviewJournal of the Society for Cardiovascular Angiography & Interventions

Intravascular Lithotripsy for Calcified Left Main Artery Disease.

Michael S Lee, Dean J Kereiakes, Richard A Shlofmitz, Evan Shlofmitz, Gary S Mintz, Ziad A Ali, Duk-Woo Park, Seung-Jung Park

Abstract readReview
In one paragraph

Review in Journal of the Society for Cardiovascular Angiography & Interventions. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Management of Stent Underexpansion and Aorto-ostial Lesions.Interventional cardiology (London, England) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michael S LeeInnovative Medical Solutions, Los Angeles, California.
Dean J KereiakesThe Carl and Edyth Lindner Research Center at The Christ Hospital, Cincinnati, Ohio.
Richard A ShlofmitzSt. Francis Hospital & Heart Center, Roslyn, New York.
Evan ShlofmitzSt. Francis Hospital & Heart Center, Roslyn, New York.
Gary S MintzCardiovascular Research Foundation, New York, New York.
Ziad A AliSt. Francis Hospital & Heart Center, Roslyn, New York.
Duk-Woo ParkAsan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Seung-Jung ParkAsan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Left main coronary artery disease subtends a large area of potentially jeopardized myocardium. Percutaneous coronary intervention for severe left main coronary artery disease is a reasonable treatment option for select patients. Severe coronary artery calcium of the left main artery increases the complexity of percutaneous coronary intervention and is associated with increased risk of periprocedural complications and worse long-term clinical outcomes. Intravascular lithotripsy (IVL) utilizes sonic pressure waves to modify severe coronary artery calcium and has emerged as a safe and effective alternative to coronary atherectomy. However, left main lesions were excluded from regulatory approval clinical trials of IVL. Herein, we review all available data regarding the use of IVL treatment for severe left main coronary artery disease.

Indexed as

coronary artery calcificationintravascular lithotripsyleft main artery

Identifiers

PMID39129890
PMCPMC11308112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.